Publication | Open Access
Effects of Shuanghuanglian oral liquids on patients with COVID-19: a randomized, open-label, parallel-controlled, multicenter clinical trial
46
Citations
22
References
2021
Year
Covid-19 PandemicAntiviral TherapyInfection ControlCovid-19 EpidemiologyClinical Infectious DiseaseMedicineMulticenter Clinical TrialCovid-19Shuanghuanglian Oral Liquids
| Year | Citations | |
|---|---|---|
Page 1
Page 1